Eric A. Collisson

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer

Matthew H. G. Katz, Qian Shi, Syed A. Ahmad et al. · JAMA Surgery · 2016 · 449 citations · Full text

Medicine, Oncology, Surgery +16

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas

Matthew H. G. Katz, Qian Shi, Jeff Meyers et al. · JAMA Oncology · 2022 · 281 citations · Full text

Medicine, Oncology, Surgery +10

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Matthew H. G. Katz, Fang‐Shu Ou, Joseph M. Herman et al. · BMC Cancer · 2017 · 189 citations · Full text

Medicine, Oncology, Surgery +16

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Matthew H. G. Katz, Qian Shi, Jeffrey P. Meyers et al. · Journal of Clinical Oncology · 2021 · 144 citations

Medicine, Oncology, Radiation Oncology +13

Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

Avital Klein-Brill, Shlomit Amar-Farkash, Gabriella Lawrence et al. · JAMA Network Open · 2022 · 93 citations · Full text

Medicine, Oncology, Pharmacology +16